AscendEX
Seed–Series B
Investment thesis
Ascendex believes that sustainable growth for mid-market organizations requires more than project delivery—it demands building robust technology foundations designed with awareness of upstream dependencies, downstream impacts, and long-term governance. The firm takes a holistic approach to digital transformation, enabling clients to scale their operations effectively through strategic technology enablement.
Source: firm website, verified Jul 21, 2026.
Frequently asked questions
- What stage does AscendEX invest at?
- AscendEX invests at the Seed, Series A, Series B stages.
- What sectors does AscendEX focus on?
- AscendEX focuses on Enterprise Software.
Similar investors
83North is a lean venture capital partnership of four equal general partners that has operated for 19 years. The firm invests globally across the US, Europe, and Israel, and in 2025 raised what it describes as its final fund, shifting focus toward selectively pursuing new opportunities while supporting existing portfolio companies.
8VC is a technology investment firm focused on building and investing in ambitious companies across life sciences, healthcare, manufacturing, enterprise, logistics, and defense sectors, with particular emphasis on operational intelligence and data-driven decision-making.
a16z is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz that invests in seed through growth-stage technology companies across multiple sectors including AI, healthcare, consumer, crypto, enterprise, fintech, and gaming. The firm manages over $100 billion in assets and operates a distinctive platform model with a large team of operators supporting founders throughout their journey.
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.